UNITED BENEFITS HOLDING is Acquiring “Silver Forum” as a Share Deal in Wroclaw: Vienna Holding Company’s First Property in Poland
10.3.2023 11:45:00 EET | Business Wire | Press release
UNITED BENEFITS HOLDING is entering the Polish real estate market: By acquiring the 16,000 square meter “Silver Forum” office building in Wroclaw, the full-service provider for real estate services is positioning itself along the entire value chain. The company plans to optimize the property with a focus on ESG standards and mobility, thus leveraging the property’s value-add potential. The core vision: a modern office complex at the gates of the historic city center. United Benefits Holding plans to redesign the facade and restructure the interior to allow for more flexibility and multiple uses. A manage-to-core strategy will be adopted to reposition the property in the marketplace as a new work property.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230310005014/en/
By acquiring the 16,000 square meter “Silver Forum” office building in Wroclaw, the full-service provider for real estate services is positioning itself along the entire value chain (c) Cushman & Wakefield
Michael Klement, CEO of United Benefits Holding: “We are delighted to have acquired an attractive commercial and office property in Wroclaw with the Silver Forum. Wroclaw is the third largest city in Poland. The country with the lowest recession rate in the EU – this is another factor that persuaded us to enter this market over the long term.” With its subsidiary INVESTER United Benefits as project developer, the Group aims to develop the property architecturally and with a view to fulfilling sustainability requirements, so the Group can reposition it on the market. The expansion and conversion plans provide for a variety of public areas for incentives and meetings. Healthy, sustainable restaurants will also be established here to make the Silver Forum attractive for tenants, users and the entire neighborhood. “We want to take the overall quality of experience to a new level and reduce ongoing operating costs for tenants in the long term. Our experienced subsidiary EKAZENT will handle the asset management,” says Klement.
Silver Forum
The office building was built in 2007. The property, which covers an area of more than 9,000 square meters, has around 16,000 square meters of usable space on seven above-ground floors. The underground parking garage in the basement offers 165 parking spaces, and there are 133 more on the surrounding site. Access to the building, with its U-shaped floor plan and two distinctive glass towers, is provided from three entrances. The investments, including the Capex package, focus mainly on the facade design, creating a green facade, and other sustainability concepts. Floor space is being structured more flexibly, spatial and technical facilities are being modernized and upgraded, and the heating technology is being improved. The future floor space concept opens up connected spaces for large companies, and fully equipped flex offices and high-quality communal areas for small startups or companies that are only temporarily based in Wroclaw. United Benefits Holding is aiming for full occupancy of the property as part of repositioning it on the market. There are also plans for certifications such as LEED and BREEAM IN-USE.
Selecting a location in the EU’s sixth-largest economy
Poland is one of the most economically stable countries in the EU. With a 3.5% drop in GDP in 2020, it recorded the lowest recession rate in the EU during the coronavirus pandemic. With regard to the specific choice of location, Michael Klement remarks: “Wroclaw is now the second largest office market among Poland’s regional cities after Krakow. Up to now, however, development activity here has been relatively low, while tenant activity has been on the rise. The city is one of the most sought-after IT locations in Europe. There is clearly a demand, but high-quality options for future-proof working environments are lacking. Today, however, in the age of work-life blending, these are in high demand.” The Silver Forum is a ten-minute drive from the historic city center of Wroclaw, famous for its many World Heritage buildings and institutions. Not only is it easily reached by car, it is also very well connected to the more environmentally friendly public transport system: It takes about 20 minutes to get from the Silver Forum to the historic City Hall by streetcar lines 3, 10 and 33. These are also crucial criteria for selecting the property: The Forum is located not far from one of the most beautiful historic city centers in Poland. There are hotels and recreational facilities such as sports centers within walking distance.
Group expertise in value-add strategies
United Benefits Holding and its subsidiaries have a wealth of experience in value-add strategies, which, according to Klement, are always the result of a successful collaboration between acquisition, project development, asset management, investment management and sales. The Silver Forum is a classic value-add property with the potential to increase in value by adopting targeted measures. This is because the location and transport links are good, and the underlying fabric of the property is of high quality. In light of the current market development, the potential of value-add properties is on the rise. “We believe that the future lies in redevelopment, redensification and repositioning. We prevent properties like these from becoming stranded assets by redeveloping and repositioning them, and by applying our special ‘Manage to ESG’ expertise in existing buildings. The Group’s many years of experience enable us to take effective remedial action in complex real estate projects and develop new concepts,” explains Klement.
Services for third parties: Group also active as service developer and service asset manager in Poland
The real estate group plans to use its services not only for its own projects, but also to offer them to other companies that are already active in Poland or intend to enter the market. "Sometimes there is a lack of resources or certain areas of expertise to successfully implement a project. Or there is a lack of specific market knowledge. We want to close these gaps with Invester United Benefits and Ekazent Management in Poland by bringing in our know-how and the vast experience of our employees in this market to analyze and optimize projects holistically," states Klement. Whether as a developer or asset manager, he says United Benefits Holding's goal is to provide real estate companies with a comprehensive service that supports them at every stage of the project. "We are convinced that our services will help other real estate companies in the Polish market to establish - and expand - their business."
About United Benefits Holding
United Benefits Holding is an independent real estate service provider with a holistic approach. In cooperation with its subsidiaries INVESTER United Benefits (Development), EKAZENT Management and WEALTHCORE Investment Management, the Group initiates, develops, realizes and manages real estate investments in the German-speaking market and provides a full range of services and processes along the entire value chain of property investments. In line with the company’s clear ESG strategy, all investments focus on independence, transparency and social justice as well as reducing carbon emissions and creating sustainable value. The group employs approximately 90 people and manages a volume of some 1.8 billion euros.
For more information, please see www.ub-holding.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230310005014/en/
Contact information
PRESS CONTACT
S
CRIVO Public Relations
Agency contact: Tristan Thaller
Tel: + 49 89 45 23 508 15
Email: tristan.thaller@scrivo-pr.de
Website: www.scrivo-pr.de
United Benefits Holding GmbH
Company contact: Sarah Gallei
Tel: + 43 664 805 33 240
Email: s.gallei@ub-holding.com
Website: ub-holding.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
